27 results on '"Muller, Ilaria"'
Search Results
2. Subacute thyroiditis in the SARS-Cov-2 era: a multicenter prospective study
3. Alemtuzumab-induced thyroid eye disease successfully treated with a single low-dose of rituximab
4. Patients with Covid-19 induced atypical thyroiditis have thyroid-resident memory T-cells specific for SARS-CoV-2
5. Increased risk of Graves' orbitopathy following Covid-19 vaccination
6. Long-term outcome of thyroid abnormalities in patients with severe Covid-19
7. Graves' orbitopathy and subacute thyroiditis related to SARS-CoV-2 infection or vaccination: the experience of a single centre in milan, italy
8. Study of target tissue-resident immune cells in graves' disease and orbitopathy (star-GO): preliminary findings with a novel extensive immunophenotyping panel
9. Alemtuzumab-induced graves' orbitopathy successfully treated with a single dose of rituximab
10. Thyroid dysfunction related to SARS-CoV-2 vaccination: the experience of a single center in Milan
11. Impact of Covid-19 disease on thyroid function: longitudinal study
12. Subacute thyroiditis (SAT) during the COVID-19 pandemic: preliminary data from the [ldquo]ESE Covid Grant 2021[rdquo] project
13. Efficacy of the Anti-BAFF monoclonal antibody belimumab vs methylprednisolone in active moderate-severe graves orbitopathy: Preliminary analysis of a randomized controlled trial
14. Evolution of SARS-CoV-2 related atypical thyroiditis
15. Comparison between the efficacy of the Anti-BAFF monoclonal antibody belimumab vs methylprednisolone in active moderate-severe graves’ orbitopathy: an interim analysis
16. Long-term cardiometabolic effects of maternal sub-optimal gestational thyroid function and relative treatment in the Controlled Antenatal Thyroid Screening (CATS) study II
17. The randomised probiotic trial of indigo study (investigation of novel biomarkers and definition of role of the microbiome in Graves' orbitopathy)
18. 2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution Therapy
19. Controlled Antenatal Thyroid Screening (CATS) II: long-term cardiometabolic effects of treating maternal sub-optimal thyroid function
20. Detecting blood micro-RNAs and proteins associated with Graves' disease and orbitopathy
21. Autoantibodies to the thyrotropin receptor in Alemtuzumab-induced thyroid autoimmunity: determination of their biological activity, and possible role as predictive marker of disease
22. TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)
23. Thyroid autoimmunity as a biomarker of breast cancer outcome: large-scale study using data from the Taxotere as Adjuvant Chemotherapy Trial (TACT: CRUK01/001)
24. Graves' disease with fluctuating thyroid status and hypothyroidism with positive anti-TSH receptor antibody levels - distinctive autoimmune side-effects following alemtuzumab therapy for multiple sclerosis
25. Controlled Antenatal Thyroid Screening Study; Obstetric Outcomes
26. TSH and free-T3 correlate negatively and independently with bone mineral density in adults with subclinical hypothyroidism
27. Adverse metabolic correlations relate to free T3 levels in subclinical hypothyroidism; common FOXE1 polymorphisms associate with blood pressure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.